| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.32▼ | 4.29▼ | 4.31▼ | 4.32▼ | 4.53▼ |
| MA10 | 4.30▼ | 4.34▼ | 4.42▼ | 4.42▼ | 4.83▼ |
| MA20 | 4.31▼ | 4.46▼ | 4.44▼ | 4.63▼ | 6.08▼ |
| MA50 | 4.40▼ | 4.36▼ | 4.34▼ | 4.94▼ | 8.98▼ |
| MA100 | 4.49▼ | 4.34▼ | 4.65▼ | 6.29▼ | 12.10▼ |
| MA200 | 4.37▼ | 4.66▼ | 4.68▼ | 8.39▼ | 14.64▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | -0.029▼ | -0.029▼ | -0.013▼ | -0.012▼ |
| RSI | 40.484▼ | 39.375▼ | 43.704▼ | 40.778▼ | 28.794▼ |
| STOCH | 73.131 | 8.973▼ | 17.393▼ | 27.227 | 12.176▼ |
| WILL %R | -54.545 | -86.111▼ | -89.130▼ | -81.159▼ | -90.102▼ |
| CCI | -14.493 | -60.427 | -91.974 | -51.500 | -99.178 |
|
Monday, May 10, 2021 04:30 AM
On track to initiate Phase 1/2 trial of VY-HTT01 for Huntington’s disease in the fourth quarter of 2021 - 8 presentations at American Society of Gene and Cell Therapy (ASGCT) conference, including new ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/05/21 | 4.50 | 4.60 | 4.24 | 4.29 | 224,562 |
| 12/05/21 | 4.30 | 4.72 | 4.27 | 4.47 | 386,430 |
| 11/05/21 | 3.96 | 4.50 | 3.96 | 4.40 | 550,297 |
| 10/05/21 | 4.28 | 4.32 | 3.90 | 4.11 | 715,207 |
| 07/05/21 | 4.38 | 4.47 | 4.22 | 4.31 | 315,332 |
| 06/05/21 | 4.28 | 4.39 | 4.21 | 4.38 | 582,576 |
| 05/05/21 | 4.49 | 4.57 | 4.21 | 4.28 | 418,832 |
| 04/05/21 | 4.61 | 4.62 | 4.27 | 4.46 | 734,772 |
| 03/05/21 | 4.89 | 4.98 | 4.65 | 4.68 | 405,723 |
| 30/04/21 | 4.87 | 5.00 | 4.72 | 4.82 | 505,380 |
|
|
||||
|
|
||||
|
|